Business Description
Delta-Fly Pharma Inc
ISIN : JP3549370009
Share Class Description:
TSE:4598: Ordinary SharesTotal Employee Number:
13Description
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.14 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.8 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year FCF Growth Rate | 16.4 | |||||
3-Year Book Growth Rate | -72.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.68 | |||||
9-Day RSI | 36.81 | |||||
14-Day RSI | 37.65 | |||||
3-1 Month Momentum % | -35.29 | |||||
6-1 Month Momentum % | -48.64 | |||||
12-1 Month Momentum % | -81.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.4 | |||||
Shareholder Yield % | -77.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -275.42 | |||||
ROA % | -182.43 | |||||
ROIC % | -2005.34 | |||||
3-Year ROIIC % | 14056.32 | |||||
ROC (Joel Greenblatt) % | -2305.66 | |||||
ROCE % | -271.95 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 48.08 | |||||
Price-to-Tangible-Book | 48.06 | |||||
EV-to-EBIT | -1.95 | |||||
EV-to-EBITDA | -1.95 | |||||
EV-to-FCF | -1.04 | |||||
Earnings Yield (Greenblatt) % | -51.28 | |||||
FCF Yield % | -88.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Delta-Fly Pharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | |||
| EPS (TTM) (円) | -77.04 | ||
| Beta | -0.5466 | ||
| 3-Year Sharpe Ratio | -0.57 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 74.19 | ||
| 14-Day RSI | 37.65 | ||
| 14-Day ATR (円) | 6.334121 | ||
| 20-Day SMA (円) | 128.85 | ||
| 12-1 Month Momentum % | -81.49 | ||
| 52-Week Range (円) | 116 - 771 | ||
| Shares Outstanding (Mil) | 14.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Delta-Fly Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Delta-Fly Pharma Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Delta-Fly Pharma Inc Frequently Asked Questions
What is Delta-Fly Pharma Inc(TSE:4598)'s stock price today?
The current price of TSE:4598 is 円124.00. The 52 week high of TSE:4598 is 円771.00 and 52 week low is 円116.00.
When is next earnings date of Delta-Fly Pharma Inc(TSE:4598)?
The next earnings date of Delta-Fly Pharma Inc(TSE:4598) is .
Does Delta-Fly Pharma Inc(TSE:4598) pay dividends? If so, how much?
Delta-Fly Pharma Inc(TSE:4598) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Delta-Fly Pharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers